Pharma channel feed

‘The sleep­ing gi­ant is wak­ing up’: FTC rais­es the pres­sure on phar­ma deal­mak­ing

Last year
Deals
In Focus

Physi­cians rate Janssen, Mer­ck and No­vo Nordisk best for cus­tomer ex­pe­ri­ence in US — sur­vey

Last year
Marketing

Brook­ings of­fers ideas on how to im­prove short­ages of ster­ile in­jecta­bles

Last year
Manufacturing

Mod­er­na 'laser-fo­cused' on AI, from clin­i­cal de­vel­op­ment to mar­ket­ing: #Can­nes­Lions2023

Last year
AI
Marketing

Aldeyra suf­fers re­jec­tion in rare eye can­cer due to 'lack of sub­stan­tial ev­i­dence' but seeks use un­der Ex­pand­ed Ac­cess

Last year
FDA+

FTC asks ap­peals court to re­verse de­ci­sion in po­ten­tial an­titrust case against Ab­b­Vie, gener­ic man­u­fac­tur­ers

Last year

Lupin wins first FDA ap­proval for gener­ic ver­sion of Boehringer In­gel­heim block­buster Spiri­va

Last year
FDA+

GSK dou­bles down on menin­gi­tis B aware­ness with new Life­time doc­u­men­tary host­ed by Soleil Moon Frye

Last year
Marketing

'On track to be­come a block­buster': FDA ap­proves in­jectable form of ar­genx's au­toim­mune drug

Last year
FDA+

Eli Lil­ly, Boehringer In­gel­heim get ap­proval to ex­pand Jar­diance, Syn­jardy la­bels to kids with type 2 di­a­betes

Last year
FDA+

No­vo Nordisk sues unau­tho­rized semaglu­tide com­pounders, tem­pers ex­pec­ta­tions for We­govy's glob­al roll­out

Last year
Marketing

Tri­bunal dis­miss­es Boehringer In­gel­heim's li­a­bil­i­ty claim against Sanofi in Zan­tac case

Last year
Law

Bi­par­ti­san bill seeks to tight­en the do­mes­tic phar­ma sup­ply chain

Last year
Manufacturing

Mar­ket­ingRx roundup: Eli Lil­ly’s mar­ket­ing chief at Cannes Li­ons, Bio­gen rais­es more Alzheimer’s aware­ness

Last year
Marketing

Phar­ma big win­ners at Cannes ad fes­ti­val in­clude Hori­zon, As­traZeneca, Eli Lil­ly and AS­CO: #Can­nes­Lions2023

Last year
Marketing

Pfiz­er flex­es its cre­ative trans­for­ma­tion at Cannes ad fes­ti­val: #Can­nes­Lions2023

Last year
Marketing

Bay­er, GSK's Vi­iV among health and well­ness win­ners at Cannes cre­ativ­i­ty fes­ti­val: #Can­nes­Lions2023

Last year
Marketing

As­traZeneca pon­ders a Chi­na phar­ma spin­off to pro­tect it­self from geopo­lit­i­cal fall­out — FT

Last year
China

As­traZeneca scraps oral GLP-1 af­ter PhI ‘does not meet that am­bi­tion’ of trump­ing the com­pe­ti­tion

Last year
R&D

Ab­b­Vie's Phar­ma­cyclics files patent suit against BeiGene over BTK ri­val Brukin­sa

Last year
Law

Eli Lil­ly’s mi­graine pre­ven­tion drug Em­gal­i­ty not su­pe­ri­or to Pfiz­er’s Nurtec ODT in head-to-head

Last year
R&D

Bi­par­ti­san group of sen­a­tors calls for ways to im­prove 340B drug dis­count pro­gram

Last year

Cannes Li­ons en­tries for phar­ma, health & well­ness awards sig­nal re­turn to busi­ness as usu­al

Last year
Marketing

FDA ap­proves Roche’s sec­ond CD20xCD3 bis­pe­cif­ic in cer­tain lym­phomas

Last year
R&D
First page Previous page 119120121122123124125 Next page Last page
A service from the Financial Times